Log in  First Connection?

Oncology ImagingArchives

A transformer-based prognostic signature integrating tumor and body composition CT images predicts postoperative recurrence in gastric cancer

 Published on 22/05/2026 |  Original article (Full-text)  | Chen Qiuying et al. | npj Digital Medicine 2026; 9(1): 12

Gastric cancer (GC) ranks as the fifth most common cancer and the fifth leading cause of cancer-related mortality worldwide1. Although the prognosis of GC patients is gradually improving, more than half of patients remain suffering recurrence, even after curative resection2,3. Reliable preoperative assessment...

Comparison of reduced FOV diffusion-weighted imaging of rectal cancer at 5.0T ultra-high field versus 3.0T MRI: image quality and histopathological T staging

 Published on 15/05/2026 |  Original article (Full-text)  | Dong Xue et al. | BMC Medical Imaging 2025; 26(1): 29

Colorectal cancer ranks as the third most frequently diagnosed malignancy globally, with approximately 30–35% of cases originating in the rectum [1]. Owing to its exceptional soft tissue resolution and capacity to capture both anatomical and functional details, magnetic resonance imaging (MRI)...

Laparoscopic ultrasound versus intraoperative gastroscopy for tumor localization in laparoscopic gastrectomy: a comparative cohort study

 Published on 08/05/2026 |  Original article (Full-text)  | Yadav Dipesh Kumar et al. | BMC Surgery 2025; 26(1): 48

Gastric cancer remains a significant global health burden, ranking as the fifth most common malignancy and the third leading cause of cancer-related mortality worldwide. Recent estimates indicate approximately 970,000 new cases and 660,000 deaths annually as of 2022 [1]. Nations with advanced healthcare...

[18F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study)

 Published on 01/05/2026 |  Original article (Full-text)  | Triemstra Lianne et al. | BMC Cancer 2025; 26(1): 135

Gastric cancer is the third leading cause of cancer-related death worldwide [1]. In most Western countries, curative treatment for locally advanced gastric cancer includes perioperative chemotherapy and gastrectomy [2, 3, 4–5]. Despite this multimodal approach, the prognosis remains poor, with...